Panacea Life Sciences HoldingsPLSH EBIT per Share is $0.06 as of Sep. 2025. The stock has 6 warning signs investors should review. Among 809 Drug Manufacturers companies, Panacea Life Sciences Holdings ranks worse than 77.63% on this metric.
Panacea Life Sciences Holdings's EBIT per Share for the
three
months ended in Sep. 2025 was $-0.00.
Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2025 was $0.06.
During the past 3 years, the average EBIT per Share Growth Rate was -11.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Panacea Life Sciences Holdings's EBIT per Share or its related term are showing as below:
PLSH'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -11.6 Med: -11.6 Max: -11.6
Current: -11.6
During the past 4 years, the highest 3-Year average EBIT per Share Growth Rate of Panacea Life Sciences Holdings was -11.60% per year. The lowest was -11.60% per year. And the median was -11.60% per year.
PLSH's 3-Year EBIT Growth Rate is ranked worse than 77.63% of 809
companies
in the Drug Manufacturers industry
Industry Median: 7.6
vs PLSH: -11.60
Panacea Life Sciences Holdings (OTCPK:PLSH) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Panacea Life Sciences Holdings EBIT per Share Related Terms
Panacea Life Sciences Holdings EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Panacea Life Sciences Holdings EBIT per Share Chart
EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.06
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Panacea Life Sciences Holdings (PLSH) has a EBIT per Share of $0.06 as of Sep. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Panacea Life Sciences Holdings and its competitors. According to the industry distribution chart, Panacea Life Sciences Holdings ranks #628 out of 809 companies in the Drug Manufacturers industry, placing it in the top 77.6%.
Is Panacea Life Sciences Holdings' EBIT per Share too high?
Panacea Life Sciences Holdings' current EBIT per Share is $0.06. The Drug Manufacturers industry median EBIT per Share is 7.60. Panacea Life Sciences Holdings' value of $0.06 is 99.2% below this industry median. Based on the distribution chart, Panacea Life Sciences Holdings ranks #628 out of 809 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Panacea Life Sciences Holdings' EBIT per Share compare to NPHC and OWPC?
According to the Drug Manufacturers industry distribution chart, Panacea Life Sciences Holdings ranks #628 out of 809 companies for EBIT per Share. This places Panacea Life Sciences Holdings in the lower half of its industry. The industry median EBIT per Share is 7.60. Panacea Life Sciences Holdings' value of $0.06 is 99.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Drug Manufacturers company?
The median EBIT per Share among Drug Manufacturers companies is 7.60, based on 809 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Panacea Life Sciences Holdings's current EBIT per Share of $0.06 is 99.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Panacea Life Sciences Holdings and its competitors. For the Drug Manufacturers industry, the median EBIT per Share is 7.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Panacea Life Sciences Holdings's current EBIT per Share is $0.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Panacea Life Sciences Holdings stock overvalued right now?
Panacea Life Sciences Holdings (PLSH) has a current EBIT per Share of $0.06. The current EBIT per Share is $0.06 and 99.2% below the Drug Manufacturers industry median of 7.60. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Panacea Life Sciences Holdings (PLSH), the current EBIT per Share is $0.06 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Panacea Life Sciences Holdings Business Description
Panacea Life Sciences Holdings Inc is a holding company organized as a plant-based natural health ingredient and product company, specializing in the development, manufacturing, research, and distribution of products and rapidly growing natural health and wellness market segment for both humans and animals. The company also offers the purest natural remedies within its branded product lines for every aspect of life: PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure and PANA Life.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PLSH has been successfully added to your 